The Role of Intra-Patient Variability of Tacrolimus Drug Concentrations in Solid Organ Transplantation: A Focus on Liver, Heart, Lung and Pancreas
Tacrolimus, the keystone immunosuppressive drug administered after solid organ transplantation, presents a narrow therapeutic index and wide inter- and intra-patient pharmacokinetic variability (IPV). The latter has been fairly studied in kidney transplantation, where it could impact outcomes. Howev...
Main Authors: | Gwendal Coste, Florian Lemaitre |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/2/379 |
Similar Items
-
Tacrolimus intra-patient variability in pediatric liver transplantation
by: WU Haoxiang, LÜ Zicheng, HOU Yuchen, ZHANG Zijie, QIAO Ziyun, FENG Hao, XIA Qiang
Published: (2022-05-01) -
Comparison of different methods to assess tacrolimus concentration intra-patient variability as potential marker of medication non-adherence
by: Barbora Kostalova, et al.
Published: (2022-10-01) -
Monitoring of tacrolimus concentration after kidney or heart transplantation - the importance of intra-subject variability parameters
by: Agnieszka Małgorzata Cios, et al.
Published: (2022-11-01) -
Tacrolimus—why pharmacokinetics matter in the clinic
by: Lino Henkel, et al.
Published: (2023-08-01) -
Tacrolimus Pharmacokinetic and Pharmacogenomic Differences between Adults and Pediatric Solid Organ Transplant Recipients
by: Amy Lu, et al.
Published: (2010-09-01)